Submitted by Anonymous (not verified) on 26 March 2026 - 13:12
Human medicines European public assessment report (EPAR): Axumin, fluciclovine (18F), Date of authorisation: 21/05/2017, Revision: 20, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Axumin, fluciclovine (18F), Date of authorisation: 21/05/2017, Revision: 20, Status: Authorised